The present invention encompasses compounds of general Formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
申请公布号
EP2323992(B1)
申请公布日期
2016.07.20
申请号
EP20090781207
申请日期
2009.07.28
申请人
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
发明人
WUNBERG, TOBIAS;BRUECKNER, RALPH;KESSLER, DIRK;KRAEMER, OLIVER;MCCONNELL, DARRYL;SCHNEIDER, SIEGFRIED;VAN DER VEEN, LARS
